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Abstract
Background: The sequences of membrane-spanning domains (MSDs) on the gp41 subunit are highly conserved
among many isolates of HIV-1. The GXXXG motif, a potential helix-helix interaction motif, and an arginine residue
(rare in hydrophobic MSDs) are especially well conserved. These two conserved elements are expected to locate
on the opposite sides of the MSD, if the MSD takes a a-helical secondary structure. A scanning alanine-insertion
mutagenesis was performed to elucidate the structure-function relationship of gp41 MSD.
Results: A circular dichroism analysis of a synthetic gp41 MSD peptide determined that the secondary structure of
the gp41 MSD was a-helical. We then performed a scanning alanine-insertion mutagenesis of the entire gp41
MSD, progressively shifting the relative positions of MSD segments around the helix axis. Altering the position of
Gly694, the last residue of the GXXXG motif, relative to Arg696 (the number indicates the position of the amino
acid residues in HXB2 Env) around the axis resulted in defective fusion. These mutants showed impaired
processing of the gp160 precursor into gp120 and gp41. Furthermore, these Env mutants manifested inefficient
intracellular transport in the endoplasmic reticulum and Golgi regions. Indeed, a transplantation of the gp41 MSD
portion into the transmembrane domain of another membrane protein, Tac, altered its intracellular distribution.
Our data suggest that the intact MSD a-helix is critical in the intracellular trafficking of HIV-1 Env.
Conclusions: The relative position between the highly conserved GXXXG motif and an arginine residue around the
gp41 MSD a-helix is critical for intracellular trafficking of HIV-1 Env. The gp41 MSD region not only modulates
membrane fusion but also controls biosynthesis of HIV-1 Env.
Background
HIV-1, the retrovirus responsible for the current world-
wide AIDS pandemic, is an enveloped virus. The envel-
ope protein (Env) of HIV-1 is essential for determining
host range and for inducing the membrane fusion that
allows the virus to enter the host cell. The former and
latter functions are mediated by the SU (gp120) and the
TM (gp41) subunits of the envelope protein, respectively
[1-3]. The SU and TM are generated from a precursor
(gp160) by cellular proteases that recognize a basic
amino acid sequence between gp120 and gp41 [4-6].
This proteolytic processing is essential to generate
fusion-competent HIV-1 Env and is believed to take
place in an early Golgi region [7,8].
HIV-1 Env is anchored across lipid bilayers via its
highly conserved membrane-spanning domain (MSD)
[9]. Although the possibility of a transient alteration of
t h em e m b r a n et o p o l o g ye x i s t s[ 1 0 , 1 1 ] ,H I V - 1E n vi s
widely believed to be a type I membrane protein with a
single a-helical MSD in the steady state [12]. Two dif-
ferent models exist within the single MSD model of
HIV-1 Env. In an initial model, the MSD is supposed to
be 23 amino acid residues long, ranging from Lys683 to
Val704 in the HXB2 sequence, and has a highly con-
served hydrophilic arginine residue in the midst of its
hydrophobic amino acid sequence [13]. In an alternative
model, MSD is shorter; and the arginine residue in the
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of the lipid molecule [14,15].
The primary structure of the MSD of HIV-1 Env also
has a GXXXG motif, a motif often found at the helix-
helix interface of transmembrane a-helices [16]; it exists
upstream of the arginine residue. If an ordinary a-helix
structure is assumed for the MSD, the GXXXG motif
and arginine residue are positioned on opposite sides of
the gp41 MSD a-helix.
In vitro studies of the gp41 MSD showed a high toler-
ance for mutations. For example, the above mentioned
conserved arginine residue [17] and the GXXXG motif
can accommodate point mutations [18]. Even several
heterologous MSDs can replace the entire gp41 MSD
without deteriorating effects [17,19]. These findings led
to the notion that the specific amino acid sequence in
the gp41 MSD has no significant biological role within
the limits of the assays used. This is a curious notion
since the sequence is quite conserved in nature, despite
the virus being subject to very strong sequence diversifi-
cation from errors in reverse transcription.
In fact, other studies have suggested that the specific
sequence of the gp41 MSD plays a role in the function
of gp41 [20,21]. We have shown that replacing the gp41
MSD with MSDs derived from glycophorin A or
VSV-G, each containing the GXXXG motif, severely
decreases the fusion activity of HIV-1 Env [18,22].
Furthermore, simultaneous substitution of all three gly-
cine residues, within the GXXXG motif with leucine
residues, also negatively affected the function of the
HIV-1 Env [23]. Shang et al. recently showed the impor-
tance of the GXXXG region using a unique genetic
approach [24]. These studies clearly suggested the pre-
sence of important information encoded in the sequence
of MSD. However, the nature of the code is still not
evident.
To further elucidate the structure-function relation-
ship of the gp41 MSD, we analyzed a circular
dichroism (CD) profile of the synthetic peptide corre-
sponding to the MSD and obtained the profile
expected for a-helical secondary structure. Next, we
used the envelope gene of HXB2 [25] to create a series
of alanine insertion mutants of the entire predicted
MSD. We found that alteration of the relationship
between Gly694 and Arg696 (the number indicates the
position of the amino acid residues in HXB2 Env)
around the axis of the MSD a-helix resulted in fusion
incompetent Env. These mutant Envs also showed
defects in proteolytic processing and intracellular
transport in the endoplasmic reticulum (ER) and Golgi
regions. We further showed that the intracellular
transport of HIV-1 Env is regulated by the MSD
region, through experiments that transplanted the
gp41 MSD into another membrane protein, Tac.
This transplantation led to an alteration of the intracel-
lular distribution of Tac, similar to that of HIV-1 Env.
Results
Circular dichroism analysis of the synthetic MSD peptide
in lipid shows a-helical secondary structure
T h ep r i m a r ys t r u c t u r eo ft h eg p 4 1M S Di sh i g h l yc o n -
served, and its secondary structure has been predicted
to be an a-helix based on computational algorithms
[26]. However, there are no physical data to support this
expectation. We synthesized a peptide corresponding to
a consensus HIV-1 clade B structure of the gp41 MSD
and determined its CD spectrum in lipid bilayers. The
CD profile, shown in Figure 1, has negative maxima
near 208 nm and 222 nm, indicating the presence of an
a-helical structure. Although the gp41 MSD of HIV-1
contains three glycine residues, thought to be helix-
breaking residues in soluble proteins, the dominant
structure indicated by our CD data was an a-helix.
Many glycines are found in transmembrane helices.
Addition of lysine residues at both ends was necessary
to allow us to purify the extremely hydrophobic MSD
peptide. We cannot completely exclude the possibility
that these lysine residues at the termini, especially at the
C-terminus, may stabilize the a-helical structure.
Scanning alanine-insertion mutagenesis identified the
region of gp41 MSD critical for membrane fusion
To identify the region of the gp41 MSD a-helix critical
for its function, we generated a set of alanine-insertion
mutants covering the entire predicted MSD by using the
HXB2 envelope gene. The alanine residue was chosen
because it can be well accommodated in an a-helix
[27,28]. Since previous data suggest the involvement of
the gp41 MSD in membrane fusion [18,23,24,29], mem-
brane fusion activity was determined for the mutants.
The primary structures of these mutants are shown in
Figure 2. Nomenclature is based on the positions of the
inserted alanine residues in HIV-1 Env. Therefore, 684
+A mutant indicates that the inserted alanine residue
corresponds to the 684th residue of the envelope pro-
tein. The mutant envelope gene was cloned into the
envelope expression vector, and the fusion activity of
each mutant was determined by the T7 RNA polymer-
ase transfer assay as described previously [18]. The
result is shown in Figure 3A. Among the twenty-two
mutants we generated, three showed a prominent
decrease in the fusion activity. These three are 694+A,
695+A, and 696+A; their relative fusion activities when
compared with the wild type (WT) were 37.5%, 14.0%
and 15.5%, respectively. Mutants 695+A and 696+A
showed more severe defects than 694+A. Thus the cor-
responding region from 694 to 696, the G
694LR
696
region, was shown to be critical for fusion activity.
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critical to membrane fusion
The insertion of an alanine residue affects both the
length and the phase of the a-helix. However, we
expected that the local phase might have a more impor-
tant role than the length of the MSD because all the
insertion mutants generated are expected to have the
same length of the MSD. To verify this, we inserted
one, two, three, and four alanine residues between resi-
dues 694 and 695 (Figure 2 bottom, 695+2A, 3A, and
4A) and examined the fusion activities of each resulting
mutant. The result is shown in Figure 3B. The insertion
of two residues caused a further decrease in the fusion
activity compared to the single insertion (compare 695
+A and 695+2A). However, the fusion activity slightly
recovered with the insertion of three residues, and
almost fully recovered by the insertion of four alanine
residues. It seems that there is a correlation between the
recovery of the phase of gp41 MSD a-helix and recovery
of membrane fusion activity. The observed defect in
fusion activity was not due to the increase in length but
instead to the local shift of the gp41 MSD a-helix.
To further identify residues critical for determining
the phase in the GLR region, we generated 696+2A and
695/696+2A (a combination of 695+2A and 696+2A,
Figure 2 bottom) and then compared the fusion activity
together with 695+2A. Both 695+2A and 696+2A
showed severe defects in membrane fusion (Figure 3C).
Interestingly, the combination of these two (695/696
+2A) recovered fusion activity. The phase commonly
altered in the fusion defective mutants, 695+2A and 696
+2A, but corrected in the fusion competent 695/696+2A
mutants was found to be between Gly694 and Arg696.
Thus the relationship between Gly694 and Arg696
seems to be an important factor for the membrane
fusion activity.
Analysis of the protein profile of the fusion-defective
mutants reveals impaired processing of gp160 into gp120
and gp41
We analyzed the protein profiles of these mutant Envs
by immunoblotting, using anti-gp120 and anti-gp41
antibodies (Figure 4). All mutant Envs were expressed at
comparable levels (Figure 4A); however, the fusion-
defective mutants had impaired processing of gp160,
namely more gp160 than gp120; and accordingly less
gp41 (see 694+A, 695+A, and 696+A) was observed.
This tendency was more prominent for 695+2A and 696
+2A, each of which showed severe defects in fusion. A
similar correlation between impaired processing of Env
and defective membrane fusion was observed in the
multiple alanine insertion mutants that showed defective
fusion (Figure 3C and 4B). Because the generation of
processed gp41 is a prerequisite for fusion competency,
this protein profile for inefficient gp160 processing is
consistent with the observed fusion defect. Our data
showed that the alteration in the a-helical phase in the
localized region within gp41 MSD affected processing of
gp160 into gp120 and gp41. It was also shown that
these mutants were fusion incompetent. A possibility is
that the mutations induced allosteric structural changes
o ft h ec l e a v a g es i t es ot h a tt h em u t a n tE n vw a sn o
longer processed properly by Furin or Furin-like pro-
teases. However, this idea was not supported by the
Figure 1 The circular dichroism (CD) profile of the synthetic MSD peptide. The synthetic peptide was dissolved in 15 mM DPC (n-dodecyl
pyridinium chloride), 20 mM NaPi, 150 mM NaCl. The spectrum information was collected as described in the materials and methods section.
The diagram shown is the average of eight spectra.
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cells, is cleaved into the gp120 and gp41 subunits by
commercially available Furin in vitro (Additional file 1).
We also analyzed the trimerization of Env mutants.
The trimer of 695+2A Env was detected (Additional file
2) However, the presence of less drastic yet critical
structural alterations by the mutation cannot be ruled
out completely.
Alanine insertion in the gp41 MSD can alter the
intracellular distribution of Env
Since processing of gp160 takes place in the Golgi [7,8],
we hypothesized that the defect in the processing was
derived from the defect in the intracellular trafficking of
mutant Env in the endoplasmic reticulum and Golgi
regions. To test this possibility, we examined the distri-
bution of mutant Env in the cells. We attached a FLAG
tag at the C-terminus of gp41, providing a linear epitope
that can be recognized by monoclonal antibody, M2. An
ttachment of the FLAG tag did not alter the defect in
processing present in alanine insertion mutants (data
not shown). The envelope proteins expressed in COS-7
cells were visualized by immunofluorecent assay using
the anti-FLAG monoclonal antibody. We observed that
fine, mesh-like fluorescent signals distributing within the
transfected cells were more prominent for the mutant
695+2A than the WT (Figure 5). The intensity of fluor-
escence derived from Env at the Golgi area was notably
weaker for 695+2A than for the WT. These data sug-
gested that mutant Env was defective for transport from
ER to Golgi. The level of Env expressed on the cell sur-
face, analyzed by FACS, is consistent with this observa-
tion because it is lower for the mutant than for the WT
(Figure 6).
To further verify the transport defect biochemically,
we analyzed the pattern of modification of sugar moi-
eties in the WT and mutant Env. The results are shown
in Figure 7. When treated with endoglycosidase H
(Endo H), the WT exhibited an Endo H-resistant frac-
tion of gp160 whereas almost no Endo H-resistant
gp160 was detected in the 695+2A mutant. This finding
indicated that sugar moieties attached to the mutant
envelope protein remained as high-mannose types.
However, both the WT and mutant envelope proteins
generated bands that migrated similarly after treatment
with Peptide: N-Glycosidase F (PNGase F), which
cleaves between the innermost GlcNAc, and asparagine
residues, where sugar moieties are attached. These data
further confirmed the defect of the mutant envelope
protein in transport, probably in ER-Golgi regions.
The transfer of the gp41 MSD into a foreign membrane
protein alters the intracellular distribution of chimeric
proteins
We are interested in determining whether the MSD
region alone is sufficient to induce the observed trans-
port defect in the context of other membrane proteins.
To test this possibility we have replaced the MSD of
Figure 2 Amino acid sequences of the MSD of the wild type
(WT) and Ala-insertion mutants used in this study. The
predicted MSD portion is indicated in capital letters. The inserted
alanine residue is underlined.
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Page 4 of 12Tac, the a-chain of the Interleukin-2 receptor, with the
MSD of the wild type (Tac-gp41WT) or 695+2A mutant
(Tac-gp41+2A) of gp41, and determined the intracellular
distribution of the engineered Tac proteins. We included
the intact Tac as a reference (Tac-WT). The results are
shown in Figure 8. The signals of intact Tac proteins dis-
tributed both in the cytoplasm and plasma membrane
areas. They show a fine mesh like appearance in the cyto-
plasm and are well overlapped with the signals of the ER
markers. The intact Tac proteins also showed prominent
signals at the rim of the cells suggesting efficient trans-
port to the plasma membrane (Figure 8A and 8D). There
was no overlap of signals for intact Tac and Golgi mar-
kers (Figure 8G). When the MSD of intact Tac proteins
was replaced with that of gp41 (wild type in Figure 8B
and 8E; 695+2A in C and F), the signals corresponding to
the plasma membrane areas became weaker than those
of intact Tac (Figure 8, compare A with B and C; D ver-
sus E and F). The majority of the signals was observed in
the cytoplasm, and the signals were co-localized with ER
markers (Figure 8B and 8C). There are some signals of
Tac-gp41 chimera in Golgi areas (Figure 8H and 8I). Dif-
ferent from the context of HIV-1 envelope proteins
(Figure 5E and 5F), we did not detect a discernable differ-
ence in the distribution between the wild type gp41 MSD
(Figure 8 Tac-gp41WT) and 695+2A gp41 MSD (Tac-
gp41+2A) in the Golgi areas (Figure 8H and 8I). It
appeared that the introduction of the gp41 MSD made
chimeric Tac distribute in the cytoplasmic region, mainly
ER regions, but the difference between the wild type
gp41 and 695+2A mutant became less prominent in the
context of Tac than in the context of the HIV-1 Env.
Discussion
Although the gp41 MSD has three glycine residues, our
CD analysis suggested the presence of the a-helical struc-
ture in gp41 MSD (Figure 1). This may not be a surprise,
since glycines are abundant in transmembrane helices
and glycines are viewed as helix breakers in soluble pro-
teins. A recent molecular dynamics study also supports a
helical conformation [30]. Furthermore, the replacement
of all three glycine residues with alanine residues, highly
a-helix-forming residues [27,28], did not affect the fusion
activity of gp41 [18]. Thus gp41 MSD is presumably
functional with an a-helical structure. These data, how-
ever, do not rule out the possibility of the reported tran-
sient alteration of the secondary structure of the gp41
MSD during membrane fusion [11].
Our scanning alanine insertion mutagenesis identified
the topological relationship between Gly694 and Arg696
around the MSD a-helix as a critical determinant for
the proper processing (Figure 4) and intracellular
Figure 3 The fusion activity of Ala-insertion mutants in the cell-cell fusion assay. COS-7 cells transfected with the T7 RNA polymerase
expression vector and the Env expression vector were co-cultured with 293CD4 cells transfected with a plasmid containing T7 promoter-driven
renilla luciferase reporter. After a 24-hr co-culture, the renilla luciferase reporter activity was measured and normalized to the firefly activities as
described previously [18]. The normalized renilla luciferase activities for (A) single Ala-inserted mutant of Env, (B) the mutant Env with multiple
Ala insertion, (C) mutant Env with two alanine residues inserted at positions 695 and 696 are shown. Data are the average of three independent
experiments. The error bar indicates a standard error.
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gp160 is dependent on the proper transport of the pro-
teins to the Golgi apparatus, it seemed that the observed
defect in processing might be due to a transport defect.
However, we cannot rule out the possibility of a
potential allosteric structural alteration of the Env by
mutation in the MSD as a cause for the inefficient pro-
cessing. Indeed our recent data suggested that the muta-
tions in the gp41 MSD exert allosteric conformational
changes of the ectodomain of HIV-1 Env [22].
Mutation at the cleavage site of gp160 eliminates HIV-
1 Env fusogenicity [7]. Thus, the defective membrane
fusion of our alanine insertion mutants seemed to be
derived from improper processing of gp160. However,
there are other factors contributing to the defective
fusion. Many studies have shown that mutations in
the gp41 MSD affect membrane fusion efficiency
[18,23,24,29]. In the context of 695+2A mutant, the sub-
stitution of hydrophilic arginine residue with non-polar
residues (alanine or isoleucine) rescues the defective
processing (Additional file 3); however, this could not
resolve the defective fusion (Additional file 4). These
data suggest that gp41 MSD has a role(s) in the mem-
brane fusion process itself. To reveal the exact mechan-
ism, further studies are required.
It has been reported that MSD length is crucial for the
trafficking of membrane proteins [31]. In HIV-1 Env,
length of the MSD alone does not seem to be a primary
determinant for trafficking. However, our data show
that critical information lies in the local structure of the
transmembrane a- h e l i xo fg p 4 1 .I ti sp o s s i b l et h a tt h e
alteration of structural features in the MSD region can
be sensed by host factor(s) involved in the protein qual-
ity control system. This detection could be through the
MSD region itself. In a yeast system, some proteins
involved in the vesicular transport in ER-Golgi where
target recognition was achieved via the MSD region
have been reported [32,33]. Since the distribution of our
Tac-gp41 chimera was heavily affected by the replace-
ment of the MSD region alone (Figure 8), it may sup-
port such a hypothesis. Such a hypothetical factor may
r e c o g n i z ew i l dt y p eg p 4 1M S Dv i at h eG X X X Gm o t i f
facing outward in relationship to the MSD bundle, if the
gp41 MSDs interact with each other through arginine
residues as suggested recently [30].
Notably, our alanine insertion mutation altered the
relative positioning of the GXXXG motif and arginine
residue within the gp41 MSD. Both are major interac-
tion motifs between transmembrane a-helices [34,35].
Although recent electron cryomicroscopic data [36-38]
did not provide a spatial arrangement of the gp41 MSD
portions, it is possible that there are interactions
between the gp41 MSDs during the biosynthesis of the
HIV-1 Env. Our alanine insertion may disrupt the inter-
action among MSDs. This disturbance of interhelical
interactions may result in altered intracellular transport.
The failure to reproduce differences in intracellular dis-
tribution between the wild type and 695+2A MSD, in
t h ec o n t e x to fT a c( F i g u r e8 ,B - I ) ,m a ya r i s ef r o mt h e
Figure 4 The immunoblotting analysis of wild type (WT) and
Ala-inserted mutant Env. The envelope proteins expressed in
COS-7 cells transfected with the Env expression vector were
detected with anti-gp120 antibody (for gp160 and gp120) or with
anti-gp41 antibody. The results of single- and multiple-Ala-insertion
mutants are shown in (A) and (B), respectively.
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(trimer) and Tac (monomer). Our data suggest that
mutant Env still forms a trimer (Additional file 2).
Our data clearly demonstrate that the MSD of gp41 has
important functions in the biosynthesis of HIV-1 Env,
apart from the simple anchoring and modulation of
fusion efficiency. The exact regulation mechanism of
intracellular distribution of HIV-1 Env by the MSD por-
tion is not known; however, it could be of great impor-
tance to determine whether there are any cellular factors
that specifically recognize the MSD region of HIV-1 Env.
Conclusions
We have shown that the secondary structure of the syn-
thetic peptide of gp41 MSD is an a-helix. Based on this
information, we performed a scanning alanine insertion
mutagenesis which showed that alteration of the topolo-
gical relationship between conserved GXXXG motif and
the arginine residue resulted in non-functional Env. The
mutant Env manifested a reduced fusion activity and
impaired the processing of gp160 into gp120 and gp41.
Furthermore, the intracellular transport of mutant Env
was affected in the endoplasmic reticulum and Golgi
areas. Our data suggested that the specific a-helical
structural feature of gp41 MSD controls the biosynthesis
of HIV-1 Env.
Methods
Synthesis of MSD peptides and its circular dichroism
analysis
The sequence of the peptide used is KKWYIKIFI-
MIVGGLVGLRIVFAVLSIVNRKK, which corresponds
to the consensus sequence of predicted MSD of clade B
HIV-1. The sequence of the MSD of the clade B mole-
cular clone, HXB2, used in this study differs by one
amino acid from this sequence (indicated by the under-
line, HXB2 has L instead of I at this position). Two
lysine residues were introduced at the N- and C-termini
to make the peptide more hydrophilic. The CD spectra
were measured at 25°C with Aviv Model 215 (Aviv bio-
medical Inc, Lakewood, NJ) in 15 mM DPC (n-dodecyl
pyridinium chloride), 20 mM NaPi, 150 mM NaCl. The
concentration of the peptide was 10 μM. Eight spectra
were averaged after subtracting for a DPC reference
sample.
Generation of the MSD mutants
QuikChange Site-Directed Mutagenesis kit (Stratagene, La
Jolla, CA) generated the mutants used in this study. The
plasmid, pGEM7zNB, which contains the 1.2-kb NheI-
BamHI fragment covering the env portion of
HXB2RU3ΔN ,w a su s e da sat e m p l a t ea sd e s c r i b e dp r e -
viously [18]. To facilitate the mutagenesis, silent restriction
Figure 5 The transport defect of alanine insertion mutant Env. Endoplasmic reticulum (ER) (A and B) and Golgi (C to F) regions were
visualized by fluorescence protein-conjugated ER or Golgi marker proteins (shown in green). FLAG tagged WT (A, C and E) and 695+2A Env
(B, D and F) were stained by anti-FLAG antibody and Alexa Fluor (shown in red). The close-up of the Golgi area was shown in E and F. Nuclei of
cells were stained with Hoechst 33258 (shown in blue).
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near the MSD coding region. The complementary oligo-
nucleotide pairs containing an inserted codon, GCC, for
the alanine residue were cloned by using the HindIII, SpeI,
and BsiwI sites. Multiple Ala-insertion mutants were made
based on the single-insertion mutants. The complemen-
tary oligonucleotide pairs used were: 695+A,
GGAGGCTTGG TAGGTGCTTT AAGAATAGTT
TTT/AAAAACTATT CTTAAAGCAC CTACCAAGCC
TCC, 696+A, GGCTTGGTAGGTTTAGCTAGAA-
TAGTTTTTGCT/AGCAAAAACTATTCTAGCTAAAC
CTACCAAGCC,695+2A,GAGGCTTGGTAGGTGCTG
CCTTAAGAATAGTTTTTGC/GCAAAAACTATTCT-
TAAGGCAGCACCTACCAAGCCTC,695+3A, GTAG
GAGGCTTGGTAGGTGCGGCCGCATTAAGAATAG-
TTTTTGCTGTACGTACAGCAAAAACTATTCTTA-
ATGCGGCCGCACCTACCAAGCCTCCTAC, 695+4A,
GGAGGCTTGGTAGGTGCGGCCGCAGCCTTAA-
GAATAGTTT TTGCTGTAC/GTACAGCAAAAAC-
TATTCTTAAGGCTGCGGCCGCACCTACCAAGCCT
CC,696+2A, GCTTGGTAGGTTTAGCTGCCAGAA-
TAGTTTTTGCTG/CAGCAAAAACTATTCTGGCAG
CTAAACCTACCAAGC,695/696+2A, GAGGCTTGG-
TAGGTGCTGCCTTAGCTGCCAGAATAGTTTTT
GCTG/CAGCAAAAACTATTCTGGCAGCTAAGG-
CAG CACCTACCAAGCCTC. The NheI-BamHIf r a g -
ment of pGEM7zNB containing the expected mutations
was cloned back to pElucEnv [18] or pElucEnv-3FLAG
Env (see below) expression vectors.
Figure 6 Surface expression level of Env. The cell surface expression level of envelope proteins for WT and Ala-insertion mutants on
transfected COS-7 cells was determined by flow cytometry using anti-gp120 antibody.
Figure 7 The analysis of glycosylation of WT and mutant Env.
The FLAG-tagged Env purified from transfected COS-7 cells was
treated with Endo H or PNGase F glycosidase. The treated protein
was separated by SDS-PAGE and detected by immunoblotting
analysis using anti-FLAG antibody. The asterisk shows the endo
H-resistant fraction of Env.
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the Tac protein, a-chain of Interleukin-2 receptor, with
the gp41 MSD was custom synthesized (GenScript, Pis-
cataway, NJ). The derivatives of this construct, whose
MSD portion was replaced with those of wild type or
mutant gp41 or intact Tac, were generated by mutagen-
esis using PCR. These genes were cloned downstream of
the CMV promoter to generate the Tac-derivative
expression vectors.
Addition of the 3 × FLAG tag at the C-terminus of the
Env
A 3 × FLAG tag was added to the C-terminus of gp41
by inserting oligonucleotides corresponding to the 3 ×
FLAG tag sequence derived from the vector p3xFLAG-
CMV™-7.1 (Sigma, St. Louis, MO). Following this inser-
tion, the amino acid sequence after the C-terminus of
gp41 reads as RSARDYKDHDGDYKDHDIDYKDDDDK.
The expression vector of FLAG-tagged Env was called
pElucEnv-3FLAG Env.
Cells and antibodies
COS-7 cells, 293 cells, and 293-CD4 cells [18] were
g r o w ni nD u l b e c c o ’s modified Eagle’sm e d i u m( S i g m a ,
St. Louis, MO) supplemented with 10% fetal bovine
serum (HyClone Laboratories, Logan, UT) and penicil-
lin-streptomycin (Invitrogen, Carlsbad, CA). Cells were
kept under 5% CO2 in a humidified incubator. Anti-
gp120 polyclonal antibody was obtained from Fitzgerald
Industries International, Inc. (Concord, MA). The hybri-
doma 902 and Chessie 8 were obtained from Bruce Che-
sebro and George Lewis, respectively through the AIDS
Research and Reference Reagent Program, Division of
AIDS, National Institute of Allergy and Infectious
Figure 8 Intracelluar distribution of Tac-gp41MSD chimera. The influence of MSD in transport of Tac proteines. Endoplasmic reticulum (ER)
(A to C) and Golgi (D to I) regions were visualized by fluorescence protein-conjugated ER or Golgi marker proteins (shown in green). Halo
tagged Tac-WT (A, D and G), Tac-gp41WT (B, E and H) and Tac-gp41 695+2A Env (C, F and I) were stained by anti-Halo antibody, anti-rabbit Ig
and Alexa Fluor (shown in red). The close-up of the Golgi area was shown in G to I. Nuclei of cells were stained with Hoechst 33258 (shown in
blue).
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Anti-FLAG M2 and BioM2 were purchased from Sigma
(St Louis, MO).
Cell-cell fusion assay
Cell-cell fusion assays, using T7 RNA polymerase (T7
RNA pol) transfer, were performed as described pre-
viously [18]. Briefly, 293-CD4 cells that constitutively
express CD4 were transfected with pTM3hRL harboring
the T7 promoter-driven renilla luciferase gene by
FuGene 6 (Roche Applied Science, Mannheim, Ger-
many), and were co-cultured with COS-7 cells that had
been transfected with pCMMPT7iresGFP, a T7 RNA
polymerase expression vector, and pElucEnv containing
HIV-1 Env and firefly luciferase genes by FuGene 6.
After 12 hours of co-culture, the renilla and firefly luci-
ferase activities were measured using the Dual-Glo luci-
ferase assay system (Promega, Madison, WI). The fusion
activity, represented by renilla luciferase activity, was
normalized by firefly luciferase activity to obtain trans-
fection efficiency [18]. The polyclonal anti-halo antibody
was obtained from Promega (Promega, Madison, WI).
Immunoblotting analysis
5×1 0
4 COS-7 cells were transfected with pElucEnv by
FuGene 6 in a 24-well culture plate. Forty-eight hours
after transfection, the cells were lysed with radioimmu-
noprecipitation assay lysis buffer (0.05 M TrisCl, 0.15
M NaCl, 1% Triton X-100, 0.1% sodium dodecyl sul-
fate, and 1% sodium deoxycholate). Cell lysates were
electrophoresed (5-20% Pantera Gel, DRC, Tokyo,
Japan) and transferred to a polyvinylidene fluoride
membrane (Pall, East Hills, NY). The blot was probed
with anti-gp120 antibody (Fitzgerald, Concord, MA),
with the monoclonal anti-gp41 antibody (Chessie 8), or
with anti-FLAG M2 antibody. A biotinylated anti-spe-
cies-specific immunoglobulin (GE Healthcare Bio-
Sciences AB, Uppsala, Sweden) was used as the sec-
ondary antibody. The blot was further treated with a
streptavidin-horseradish peroxidase conjugate (GE
Healthcare Bio-Sciences AB) and Lumi-Light
plus
(Roche, Indianapolis, IN). Images were obtained with
LAS3000 (Fujifilm, Tokyo, Japan).
Immunofluorescence assay
Immunofluorescence assays were used to determine
the intracellular distribution of the envelope proteins.
For this purpose, we generated a modified envelope
expression vector called pElucEnvdeltaGFP; this is the
derivative of the previously described pElucEnv [18]
and it has the deletion of the EGFP portion. COS-7
cells transfected with pElucEnv WT or 695+2A in the
delta GFP backbone vector and ER-DsRed2 or Golgi-
YPF (Clontech) or pER-mAG1 (MBL, Nagoya, Japan)
plasmid by FuGene 6 (Roche) were treated with PBS
including 4% of PFA for 5 min at 48 hr posttransfec-
tion. Cells were permeabilized by PBS including, 0.05%
of saponin and 0.2% of BSA, for 30 min and then
stained with 20 μg/ml of bio-M2 (Sigma) antibody and
10 μg/ml of streptavidin conjugated Alexa fluor 488 or
555 (Invitrogen). In the case of Halo-tagged proteins,
polyclonal anti-Halo antibodies were used as primary
antibodies. The distributions of fluorescence in cells
were visualized using a Zeiss LSM 510 meta confocal
microscope.
Flow cytometric analysis
Flow cytometric analysis was performed as described
previously [18]. Briefly, COS-7 cells were transfected
with pElucEnv by FuGene 6 on a six-well plate. Forty-
eight hours aftertransfection, the cells were stained with
anti-gp120 monoclonal antibody 902, biotinXX anti-
mouse IgG (Invitrogen) and streptavidin-Alexa 555 in
PBS including 10% FBS. Cells were fixed with 1% paraf-
ormaldehyde in PBS and analyzed by FACS Calibur (BD
Biosciences).
Glycosidase assay
COS-7 cells transfected with pElucEnv-3FLAG by
FuGene 6 on the six-well plate were lysed with radioim-
munoprecipitation assay lysis buffer including Complete
protease inhibitor (Roche).E n v - 3 F L A Gw a sp u r i f i e d
from cell lysates by immunoprecipitation using M2 agar-
ose (Sigma) and eluted with 3XFLAG peptide (Sigma).
Purified Env-3FLAG was treated with Endo H or
P N G a s eF( R o c h e ) .F o rd i g e s t i o nb yE n d oH ,E n v -
3FLAG was boiled and digested with 0.005 unit Endo H
at 37°C for 12 hr in Endo H digestion buffer [50 mM
phosphate buffer (pH 5.8), 50 mM NaCl, 0.1 M 2-mer-
captoethanol (2-ME), 0.01% SDS]. Env-3FLAG was
boiled in PBS including 0.1 M 2-ME and 0.1% SDS and
digested by 1 unit PNGase F at 37°C for 12 hr in
PNGase F digestion buffer (74 mM TrisCl, pH 8.0;
0.74% NP-40; 0.37 M 2-ME, 0.37% SDS). Env-3FLAG
treated with glycosidase was resolved by SDS-polyacryla-
mide gel electrophoresis (10% polyacrylamide gel; DRC)
and detected by immunoblotting analysis using anti-
FLAG M2.
In vitro furin cleavage of Env
Env-3FLAG with the 695+2A mutation was purified
from COS-7 cell lysates by immunoprecipitation as
described above and treated with 0.7 units of furin
(Alexis, Lausen, Switzerland) at 30°C for 12 hr in furin-
digestion buffer (100 mM Hepes, pH 7.5; 1 mM CaCl2;
0.5% Triton X-100]). Env-3FLAG, treated with furin,
was detected by immunoblotting analysis using anti-
FLAG M2 as described above.
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At 48 hr postransfection, 293T cells transfected with
FLAG tagged WT or 695+2A Env expression vectors
were treated with 1 mM DSS for 20 min at room tem-
perature in PBS (pH 8.0). Cells were incubated with 20
mM Tris-Cl for 15 min at room temperature to stop the
reaction and then were lysed in buffer A (10 mM
H E P E S ,1 . 5m MM g C l 2 ,1 0m MK C l ,0 . 5m MD T T ,
0.05% Igepal pH 7.9). Env proteins in cellular lysate
were detected by immunoblotting analysis using anti-
FLAG antibody (see above).
Additional material
Additional file 1: Supplemental Figure 1- In vitro digestion of
mutant Env with recombinant Furin. The wild type (WT) and mutant
(695+2A) Env were prepared from transfected COS-7 cells and subjected
to digestion with recombinant Furin (rFurin) as described in the Methods
section. Mock indicates the result for the cell lysates prepared from mock
transfected cells.
Additional file 2: Suplemental Figure 2- Cross linking analysis of the
695+2A Env. The trimerization of gp160 was examined by chemical
cross linking. The cells transfected with Env expression vectors for wild
type (WT) and mutant (695+2A) were treated with the chemical cross
linker. The cell lysates were probed with the anti-FLAG antibody. The
single asterisk and the double asterisk indicate the bands for trimer and
monomer of mutant gp160, respectively. Marker: HiMark Pre-Stained
High Molecular Weight Protein Standard (Invitrogen), Mock: mock
transfection.
Additional file 3: Suplemental Figure 3A - Immunoblotting analysis
of the Arg-substitution mutants in the context of 695+2A.T h e
degree of processing of gp160 was examined by immunoblotting the
cell lysates prepared from COS-7 cells transfected with respective Env
expression vectors. The Arg residue in the context of 695+2A was
substituted with the indicated amino acid residue by the site directed
mutagenesis (columns under 2A). One letter abbreviation for an amino
acid residue is used. Mock: mock transfection, WT: wild type MSD.
Additional file 4: Suplemental Figure 3B - Fusion activities of Arg-
substitution mutants in the context of 695+2A. The fusion activities
of the mutant shown in additional file 3A were examined by a syncytia
formation assay in 293CD4 cells. Fusion activity of the WT and MSD
mutants was expressed using a fusion index (fusion index = 2x + y,
where x is the number of multinucleated cells [number of nuclei ≥ 5i n
five visual fields] and y is the number of multinucleated cells [number of
nuclei < 5 in five visual fields]) as described previously [18].
List of abbreviations
MSD: membrane-spanning domain; CD: circular dichroism; ER: endoplasmic
reticulum; WT: wild type.
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